Patents by Inventor Francisco Javier Garcia

Francisco Javier Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240157381
    Abstract: A nozzle assembly that includes an outlet conduit that exhaust to the environment, a rear sub-chamber, a liquid inlet that opens into the rear sub-chamber, a front sub-chamber in fluid communication with both the outlet conduit and the rear sub-chamber and a dividing member disposed between the front and rear sub-chambers. The dividing member includes fluid passages that provide fluid communication between the front and rear sub-chambers. The nozzle also includes an air inlet conduit configured to deliver a pressurized supersonic air stream into the front sub-chamber. The parts of the nozzle assembly are configured to give rise to first, second and third atomization stages that respectively occur in the rear sub-chamber, the front sub-chamber and at the outlet conduit.
    Type: Application
    Filed: November 18, 2022
    Publication date: May 16, 2024
    Inventors: Francisco Javier PÉREZ DEL ÁLAMO, Juan SÁNCHEZ GARCÍA CASARRUBIOS
  • Patent number: 11930808
    Abstract: A method to obtain a composition comprising an enriched population of functional mesenchymal stem cells for hypothermic transport and local administration of said enriched population of functional mesenchymal stem cells in therapy. Finally also described is the use of said enriched population of functional mesenchymal stem cells, and compositions comprising them, obtained by the described method, in autologous or allogeneic treatment of diseases susceptible to mesenchymal stem cell therapy, either by local or systemic treatments, and more particularly in the treatment of osteoarticular diseases such as degenerative disc disease, osteoarthritis, and bone repair; in lupus erythematosus, graft-versus-host disease, and other autoimmune diseases; in peripheral vascular insufficiency and other cardiovascular diseases.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: March 19, 2024
    Assignees: UNIVERSIDAD DE VALLADOLID, CITOSPIN, S.L.
    Inventors: Ana Sánchez García, Francisco Javier García-Sancho Martín, Verónica García Díaz, Mercedes Alberca Zaballos, Sandra Güemes Gutiérrez
  • Patent number: 11920559
    Abstract: A floating platform for high-power wind turbines, comprising a concrete substructure, said concrete substructure forming the base of the platform, which remains semi-submerged in the operating position, and consisting of a square lower slab on which a series of beams and five hollow reinforced concrete cylinders are constructed, distributed at the corners and the center of said lower slab; a metal superstructure supported on the concrete substructure and forming the base for connection with the wind turbine tower, said tower being coupled at the center thereof; and metal covers covering each of the cylinders, on which the metal superstructure is supported and to which vertical pillars are secured, linked together by beams, which join at the central pillar by an element whereon the base of the wind turbine tower is secured.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: March 5, 2024
    Assignees: DRAGADOS S.A., FHECOR INGENIEROS Y CONSULTORES S.A.
    Inventors: Miguel Vazquez Romero, Noelia Gonzalez Patiño, Elena Martin Diaz, Alejandro Perez Caldentey, José María Ortolano Gonzalez, Raúl Guanche Garcia, Victor Ayllon Martinez, Francisco Ballester Muñoz, Jokin Rico Arenal, Marcos Cerezo Laza, Iñigo Javier Losada Rodríguez
  • Patent number: 11889508
    Abstract: A system for managing a cellular network implemented based on O-RAN standards includes an O-DU for generating a first control-plane message requesting a first set of radio resources responsive to a scheduled uplink transmission from a user device, where the first set of radio resources includes an assigned portion of a carrier signal allocated for the uplink transmission; an interposer unit for receiving the first control-plane message, and generating a second control-plane message requesting a second set of radio resources including a remaining portion of the carrier signal; and an O-RU for receiving the first and second control-plane messages, receiving the uplink transmission, and generating user-plane message(s) including first and second digitized data correlated with the first and second control-plane messages. The interposer unit sends the first digitized data to the O-DU without sending the second digitized data, and monitors the carrier signal using the first and second digitized data.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: January 30, 2024
    Assignee: KEYSIGHT TECHNOLOGIES, INC.
    Inventors: Alan John Anderson, Francisco Javier Garcia Garcia, Jan Erik Schiefer, Michael Dieudonné
  • Publication number: 20230270340
    Abstract: The invention relates to a vein transilluminator comprising: a body formed by two arms, a plurality of LEDs housed in said arms and electrical power supply means configured to electrically power the LEDs; characterised in that the arms are joined together by means of at least one joint, said joint being configured in such a way as to allow said arms to be arranged in two different planes.
    Type: Application
    Filed: June 2, 2021
    Publication date: August 31, 2023
    Inventor: Francisco-Javier GARCIA-MINGO
  • Publication number: 20230247981
    Abstract: A method to obtain a composition comprising an enriched population of functional mesenchymal stem cells for hypothermic transport and local administration of said enriched population of functional mesenchymal stem cells in therapy. Finally also described is the use of said enriched population of functional mesenchymal stem cells, and compositions comprising them, obtained by the described method, in autologous or allogeneic treatment of diseases susceptible to mesenchymal stem cell therapy, either by local or systemic treatments, and more particularly in the treatment of osteoarticular diseases such as degenerative disc disease, osteoarthritis, and bone repair; in lupus erythematosus, graft-versus-host disease, and other autoimmune diseases; in peripheral vascular insufficiency and other cardiovascular diseases.
    Type: Application
    Filed: February 8, 2023
    Publication date: August 10, 2023
    Inventors: Ana SÁNCHEZ GARCÍA, Francisco Javier GARCÍA-SANCHO MARTÍN, Verónica GARCÍA DÍAZ, Mercedes ALBERCA ZABALLOS, Sandra GÜEMES GUTIÉRREZ
  • Publication number: 20230223733
    Abstract: The present invention relates to a method, system and device for transmitting information from an optical communication transmitter to a receiving station via a laser beam and for alignment of said laser beam emitted from said optical communication transmitter with said receiving station, wherein: said optical communication transmitter is displaced relative to said receiving station and comprises a laser, a radio receiver, a microprocessor and a liquid crystal on silicon spatial light modulator comprising a diffractive element, whereby said laser beam is emitted from said laser and is projected over an area by diffraction and reflection using said liquid crystal on silicon spatial light modulator, wherein said laser and said diffractive element are controlled by said microprocessor, wherein said laser beam has a longitudinal axis parallel to the propagation path of said laser beam, said receiving station comprises a photodiode receiver for detecting said transmitted laser beam and a radio transmitter, and sa
    Type: Application
    Filed: May 18, 2021
    Publication date: July 13, 2023
    Inventors: José Antonio CARRASCOSO HERNÁNDEZ, Francisco Javier GARCÍA DE QUIRÓS NIETO, Ignacio MORENO SORIANO
  • Publication number: 20230083529
    Abstract: There is provided mechanisms for enabling selection of service-providing NFs in a 3GPP communication network. A method is performed by an NRF. The method comprises obtaining one register request from each of the service-providing NFs. Each registration request comprises an NF profile. Each NF profile comprises a security setting attribute. The method comprises storing the NF profiles of the service-providing NFs. The method comprises obtaining a discovery request from a service-requesting NF. The request indicates an NF type. The method comprises providing a discovery response to the service-requesting NF. The discovery response comprises the NF profile of at least one of the service-providing NFs of the NF type, thereby enabling selection of the service-providing NFs. The security setting attribute may pertain to support for mutual TLS and/or for use of OAuth-2 based authorization.
    Type: Application
    Filed: January 21, 2021
    Publication date: March 16, 2023
    Inventors: Pablo MARTINEZ DE LA CRUZ, Francisco Javier GARCIA GARCIA, Jesus Angel DE GREGORIO RODRIGUEZ, Maria Esther BAS SANCHEZ
  • Publication number: 20230057133
    Abstract: The present invention relates to a pharmaceutical composition for use in the treatment and/or prevention of a central nervous system disorder, comprising a compound of formula (I): or any salt, derivative, isotope or mixture thereof, and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: December 31, 2020
    Publication date: February 23, 2023
    Applicant: ABAXYS THERAPEUTICS
    Inventor: Francisco Javier GARCIA-LADONA
  • Publication number: 20220273572
    Abstract: A solid formulation including at least one 1,2,4-oxadiazole derivative of formula (I): wherein R1, R2, R3, R4 and R5 are each independently selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy and C1-C3 thioalkyl; and citric acid and/or saccharin, wherein the molar ratio in the solid formulation between the total amount of citric acid and/or saccharin and the amount of the 1,2,4-oxadiazole derivative(s) ranges from about 2 to about 20. Also a process for manufacturing the solid composition and a method for increasing the physical stability of a 1,2,4-oxadiazole derivative of formula (I).
    Type: Application
    Filed: July 17, 2020
    Publication date: September 1, 2022
    Applicant: ABAXYS THERAPEUTICS
    Inventors: Johan WOUTERS, Kalina MAMBOURG, Francisco Javier GARCIA-LADONA
  • Publication number: 20220264301
    Abstract: A network repository function, NRF, in a core network domain of a mobile communication network is provided, wherein the NRF is configured to register network function, NF, profiles for NF discovery, and wherein NF certificates have been issued to the NFs, each NF certificate including a public key of the respective NF and at least one signature of at least one certification authority, CA. The NRF is configured to receive, from a registering NF having an NF certificate, profile information comprising an NF identity of the registering NF, an NF type of the registering NF, and at least one CA certificate of at least one CA that signed the NF certificate issued to the registering NF. The NRF is further configured to store the received profile information in a repository.
    Type: Application
    Filed: September 3, 2019
    Publication date: August 18, 2022
    Inventors: Pablo MARTINEZ DE LA CRUZ, Francisco Javier GARCIA GARCIA
  • Publication number: 20220252346
    Abstract: The invention relates to a device and method for the simultaneous lyophilisation of a plurality of biological samples ensuring the traceability of said samples intended to be housed within coded containers (1); the device comprises a diffuser block (2) comprising a plurality of openings which define receptacles (21) to house the coded containers (1), wherein the diffuser block (2) further comprises a perimeter cavity (24) configured so that the alloy surrounding each receptacle (21) is similar in all the coded containers (1), enabling high thermal homogeneity, and the receptacles (21) have through openings defining an open bottom (23) to scan the coded containers (1). Likewise, the device further comprises a transfer lid (3) to ensure the position of each container (1) when it is transferred to the diffuser block (1) and back to the starting box (4).
    Type: Application
    Filed: July 2, 2020
    Publication date: August 11, 2022
    Inventors: Andrés Celestino GARCÍA MONTERO, Alberto ORFAO DE MATOS CORREIRA E VALE, Francisco Javier GARCÍA PALOMO, Catia Daniela QUINTAS FARIA, Roberto José GARCÍA MARTÍN, Maria PÉREZ CARO
  • Publication number: 20210321606
    Abstract: A method to obtain a composition comprising an enriched population of functional mesenchymal stem cells for hypothermic transport and local administration of said enriched population of functional mesenchymal stem cells in therapy. Finally also described is the use of said enriched population of functional mesenchymal stem cells, and compositions comprising them, obtained by the described method, in autologous or allogeneic treatment of diseases susceptible to mesenchymal stem cell therapy, either by local or systemic treatments, and more particularly in the treatment of osteoarticular diseases such as degenerative disc disease, osteoarthritis, and bone repair; in lupus erythematosus, graft-versus-host disease, and other autoimmune diseases; in peripheral vascular insufficiency and other cardiovascular diseases.
    Type: Application
    Filed: September 18, 2019
    Publication date: October 21, 2021
    Inventors: Ana SÁNCHEZ GARCÍA, Francisco Javier GARCÍA-SANCHO MARTÍN, Verónica GARCÍA DÍAZ, Mercedes ALBERCA ZABALLOS, Sandra GÜEMES GUTIÉRREZ
  • Patent number: 9918808
    Abstract: The present invention relates to a dental post for supporting dental prostheses by a screw attachment and method for the manufacture thereof which provides a customizable optimum solution for each case, both from the mechanical viewpoint and from the aesthetic viewpoint, essentially comprising an upper hole into which the retaining screw is screwed for retaining the prosthesis on the post such that the upper hole can be located at any point of the surface of the post once said post has been customized in terms of the shape thereof and type of retention to the prosthesis depending on the mechanical and aesthetic needs of the type of rehabilitation suitable for each particular case.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: March 20, 2018
    Assignee: PHIBO DENTAL SOLUTIONS, S.L.
    Inventors: Francisco Javier Garcia Saban, Francesc Alsina Font, Daniel Aguilar Garcia
  • Publication number: 20160261086
    Abstract: Described herein are optical devices based on two-dimensional materials and methods for making such devices. In particular, the articles described herein are useful in the control and modulation of light via graphene mono- or multilayers. methods for improved transfer of graphene from formation substrates to target substrates. The improved articles provide exceedingly high modulation depths in vis-NIR light transmission, with small insertion losses, thus revealing the potential of graphene for fast electro-optics within such a technologically important range of optical frequencies.
    Type: Application
    Filed: March 1, 2016
    Publication date: September 8, 2016
    Inventors: Valerio Pruneri, Renwen Yu, Francisco Javier Garcia de Abajo
  • Patent number: 9363692
    Abstract: A method for operating a data processing system to determine the operational parameters of a communication system between an REC and an RE that utilizes a CPRI data link for communication. The data processing system is synchronized with the CPRI frames and determines a plurality of CPRI frame characteristics from the CPRI frames by examining a plurality of predetermined locations in the CPRI frames. The plurality of CPRI frame characteristics for one or more of the CPRI frames, and a first model of the communication system are used to generate a first broadcast frame that would be generated by the one or more CPRI frames if the first model accurately described the communication system. The first broadcast frame is tested to determine if the first broadcast frame is consistent with the first model. If the broadcast frame is inconsistent, a new model is chosen and the process repeated.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: June 7, 2016
    Assignee: Keysight Technologies, Inc.
    Inventor: Francisco Javier Garcia
  • Patent number: 9296697
    Abstract: The invention relates to the hetaryl-substituted guanidine compounds of general formula (I), enantiomeres, diastereomeres and/or tautomeres thereof, in addition to the pharmaceutically acceptable salts thereof and the prodrugs of the known compounds. The invention also relates to the use of said hetaryl-substituted guanidine compounds as binding partners for 5-HT5-receptors for treating and/or for the prophylaxis of illnesses which are modulated by a 5-HT5-receptor activity, in particular, for treating and/or for the prophylaxis of neurodegenerative and neuropsychiatric disorders, and signs, symptoms and dysfunctions associated with said disorders.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: March 29, 2016
    Assignees: Abbott Laboratories, AbbVie Deutschland GmbH & Co. KG
    Inventors: Wilhelm Amberg, Astrid Netz, Andreas Kling, Michael Ochse, Udo Lange, Charles W. Hutchins, Francisco Javier Garcia-Ladona, Wolfgang Wernet, Alfred Hahn
  • Patent number: 9277424
    Abstract: A method for operating a computer to determine the operational parameters of an LTE communication system includes an REC and an RE that communicate with one another over a data link utilizing CPRI frames that are translated into LTE frames by the RE is disclosed. The method includes synchronizing the data processing system with the CPRI frames. The computer then determines a plurality of CPRI frame characteristics from the CPRI frames by examining a plurality of predetermined locations in the CPRI frames. The CPRI frame characteristics, a CPRI frame, and a model of the LTE communication system, are used to generate a first LTE frame that would be generated by that CPRI frame if the model accurately described the LTE communication system. The first LTE frame is then tested to determine if it is consistent with the model. The process is repeated until a consistent model is found.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: March 1, 2016
    Assignee: Keysight Technologies, Inc.
    Inventor: Francisco Javier Garcia
  • Patent number: 9167593
    Abstract: An apparatus that includes a base-band input port and a processor and a method for operating the same are disclosed. The base-band input port receives digital base-band communications including a plurality of communication channels utilized in communications between an RF module and a plurality of user equipment (UE) in a cell serviced by that RF module. The processor demodulates specific channels in the digital base-band communications and extracts therefrom information specifying a unique identity for each of the UEs and a temporary identification used for communicating with that UE. The processor also extracts scheduling information identifying when one of the UEs is scheduled to upload information to the RF module and the communication channels over which the information is to be uploaded. The processor does not demodulate others of the communication channels.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: October 20, 2015
    Assignee: Keysight Technologies, Inc.
    Inventors: Colin M Arthur, Francisco Javier Garcia, Gery Verhaegen, Joeri Melis
  • Publication number: 20150281983
    Abstract: A method for operating a data processing system to determine the operational parameters of a communication system between an REC and an RE that utilizes a CPRI data link for communication. The data processing system is synchronized with the CPRI frames and determines a plurality of CPRI frame characteristics from the CPRI frames by examining a plurality of predetermined locations in the CPRI frames. The plurality of CPRI frame characteristics for one or more of the CPRI frames, and a first model of the communication system are used to generate a first broadcast frame that would be generated by the one or more CPRI frames if the first model accurately described the communication system. The first broadcast frame is tested to determine if the first broadcast frame is consistent with the first model. If the broadcast frame is inconsistent, a new model is chosen and the process repeated.
    Type: Application
    Filed: March 31, 2014
    Publication date: October 1, 2015
    Applicant: Agilent Technologies, Inc.
    Inventor: Francisco Javier Garcia